BioCentury
ARTICLE | Company News

NeXagen deal

June 21, 1993 7:00 AM UTC

Becton Dickinson took a $5 million equity position in NeXagen, in addition to funding undisclosed research costs. Patrick Mahaffy, president and CEO at privately held NeXagen, said the companies hope ...